NO COMPLETE SUPPRESSION OF GVHD WITH MONOCLONAL ANTI-CD3/4/5/8 OR 45 T-CELL ANTIBODIES IN MICE

被引：0
|
作者：
REINECKE, K [1 ]
MYSLIWIETZ, J [1 ]
KREMMER, E [1 ]
THIERFELDER, S [1 ]
机构：
[1] GESELL STRAHLEN & UMWELTFORSCH MBH,INST IMMUNOL,MUNICH,GERMANY
来源：
EXPERIMENTAL HEMATOLOGY | 1991年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：553 / 553
页数：1
相关论文
共 50 条
  • [21] Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies
    Clement, Mathew
    Pearson, James A.
    Gras, Stephanie
    van den Berg, Hugo A.
    Lissina, Anya
    Llewellyn-Lacey, Sian
    Willis, Mark D.
    Dockree, Tamsin
    McLaren, James E.
    Ekeruche-Makinde, Julia
    Gostick, Emma
    Robertson, Neil P.
    Rossjohn, Jamie
    Burrows, Scott R.
    Price, David A.
    Wong, F. Susan
    Peakman, Mark
    Skowera, Ania
    Wooldridge, Linda
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies
    Mathew Clement
    James A. Pearson
    Stephanie Gras
    Hugo A. van den Berg
    Anya Lissina
    Sian Llewellyn-Lacey
    Mark D. Willis
    Tamsin Dockree
    James E. McLaren
    Julia Ekeruche-Makinde
    Emma Gostick
    Neil P. Robertson
    Jamie Rossjohn
    Scott R. Burrows
    David A. Price
    F. Susan Wong
    Mark Peakman
    Ania Skowera
    Linda Wooldridge
    Scientific Reports, 6
  • [23] AMELIORATION OF EXPERIMENTAL LUNG METASTASIS IN MICE BY THERAPY WITH ANTI-CD3 MONOCLONAL-ANTIBODIES
    HOSKIN, DW
    STANKOVA, J
    ANDERSON, SK
    RODER, JC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (03) : 226 - 230
  • [24] A CD4+IL-4 secreting cell is required for tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies
    Punch, JD
    Bromberg, JS
    FASEB JOURNAL, 1999, 13 (05): : A982 - A982
  • [25] ANTI-CD3 MONOCLONAL-ANTIBODY (OKT3) SUPPRESSES NORMAL AND NEOPLASTIC HUMAN T-CELL AND B-CELL IN SCID MICE
    THIERFELDER, S
    ZENGERLE, U
    HOFFMANNFEZER, G
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 825 - 825
  • [26] COMPARISON OF THE MECHANISMS OF INVIVO T-CELL ANERGY INDUCED BY MITOGENIC AND NON-MITOGENIC FORMS OF ANTI-CD3 MONOCLONAL-ANTIBODIES
    SAWCHUK, S
    HIRSCH, R
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A278 - A278
  • [27] THE USE OF AN ANTI-CD3 PRIMING DOSE TO ENHANCE THE IMMUNOSUPPRESSIVE POTENCY OF MONOCLONAL AND POLYCLONAL T-CELL ANTISERA
    SHERBURNE, CG
    ONYEKABA, CO
    CONDIE, RM
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 626 - 629
  • [28] Downregulation of antigen-presenting cell functions after administration of mitogenic anti-CD3 monoclonal antibodies in mice
    Muraille, E
    Andris, F
    Pajak, B
    Wissing, KM
    De Smedt, T
    Desalle, F
    Goldman, M
    Alegre, ML
    Urbain, J
    Moser, M
    Leo, O
    BLOOD, 1999, 94 (12) : 4347 - 4357
  • [29] Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice
    Kita, Tomoyuki
    Yamashita, Tomoya
    Sasaki, Naoto
    Kasahara, Kazuyuki
    Sasaki, Yoshihiro
    Yodoi, Keiko
    Takeda, Masafumi
    Nakajima, Kenji
    Hirata, Ken-ichi
    CARDIOVASCULAR RESEARCH, 2014, 102 (01) : 107 - 117
  • [30] MONOCLONAL ANTI-CD44 ANTIBODY ACTS IN SYNERGY WITH ANTI-CD2 BUT INHIBITS ANTI-CD3 OR T-CELL RECEPTOR-MEDIATED SIGNALING IN MURINE T-CELL HYBRIDOMAS
    GUO, YJ
    MA, J
    WONG, JH
    LIN, SC
    CHANG, HC
    BIGBY, M
    SY, MS
    CELLULAR IMMUNOLOGY, 1993, 152 (01) : 186 - 199
12345